Leprosy, or Hansen’s disease, is caused by Mycobacterium leprae, a slow-growing bacterium that primarily affects the skin, nerves, and mucous membranes. While this disease can lead to severe physical consequences if left untreated. The encouraging reality is that leprosy is entirely curable.
Peptides are short chains of amino acids, the building blocks of proteins. These tiny but mighty molecules play crucial roles in the body, acting as hormones, enzymes, and signaling agents. Their natural compatibility with biological systems makes them ideal candidates for drug development.
Therapeutic enzymes are used to correct metabolic imbalances, break down harmful substances, and aid in drug delivery. They are particularly effective in enzyme replacement therapies (ERT), where patients with enzyme deficiencies receive functional enzymes to restore normal metabolic activity. Additionally, enzymes play a critical role in digestive health, cardiovascular support, and metabolic regulation.
The oncology market in 2025 is poised for continued rapid advancement, fueled by breakthroughs in technology and innovative treatment approaches. Building on the trends that shaped the oncology landscape in 2024, here’s a look at what to anticipate in the year ahead.
